Cargando…

Left Ventricular Hypertrophy Geometry and Vascular Calcification Co-Modify the Risk of Cardiovascular Mortality in Patients with End-Stage Kidney Disease: A Retrospective Cohort Study

Aim: Patients with end-stage kidney disease (ESKD) have an unparalleled risk of left ventricular hypertrophy (LVH) and vascular calcification (VC), both of which introduce excessive cardiovascular risk. However, it remains unclear whether LVH geometry co-modulates cardiovascular outcomes with VC in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chao, Chia-Ter, Liao, Min-Tser, Wu, Chung-Kuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499460/ https://www.ncbi.nlm.nih.gov/pubmed/36567124 http://dx.doi.org/10.5551/jat.63870

Ejemplares similares

Association of aortic arch and aortic valve calcifications with cardiovascular risk in patients on maintenance hemodialysis
por: Liao, Min-Tser, et al.
Publicado: (2022)

Vascular calcification and left ventricular hypertrophy in hemodialysis patients: interrelationship and clinical impacts
por: Hwang, Hyeon Seok, et al.
Publicado: (2018)

The Epigenetic Landscape of Vascular Calcification: An Integrative Perspective
por: Hou, Yi-Chou, et al.
Publicado: (2020)

Modified Cornell electrocardiographic criteria in the assessment of left ventricular hypertrophy geometry of patients with essential hypertension
por: Xu, Min, et al.
Publicado: (2020)

Sirtuin-1 and Its Relevance in Vascular Calcification
por: Lu, Chien-Lin, et al.
Publicado: (2020)

The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on Dialysis
por: Coimbra, Susana, et al.
Publicado: (2023)

Hyperkalemia masking left ventricular hypertrophy in electrocardiogram in a patient with end-stage renal disease
por: Sai Naresh, V. V., et al.
Publicado: (2008)

Lessons from effect of etelcalcetide on left ventricular hypertrophy in patients with end-stage kidney disease
por: Dörr, Katharina, et al.
Publicado: (2022)

Cardiovascular Magnetic Resonance for the Differentiation of Left Ventricular Hypertrophy
por: Burrage, Matthew K., et al.
Publicado: (2020)

Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants
por: Zhao, Xinju, et al.
Publicado: (2022)

Association between basal septal hypertrophy and left ventricular geometry in a community population
por: Gao, Lan, et al.
Publicado: (2022)

Astaxanthin Counteracts Vascular Calcification In Vitro Through an Early Up-Regulation of SOD2 Based on a Transcriptomic Approach
por: Chao, Chia-Ter, et al.
Publicado: (2020)

Low agreement between cardiologists diagnosing left ventricular hypertrophy in children with end-stage renal disease
por: Schoenmaker, Nikki J, et al.
Publicado: (2013)

Association of Arterial Stiffness and Electrocardiography-Determined Left Ventricular Hypertrophy with Left Ventricular Diastolic Dysfunction
por: Hsu, Po-Chao, et al.
Publicado: (2012)

Patterns of vascular calcification in patients with end‐stage renal disease and calcific uremic arteriolopathy
por: Koratala, Abhilash, et al.
Publicado: (2017)

Moexipril and left ventricular hypertrophy
por: Chrysant, George S, et al.
Publicado: (2007)

Left ventricular hypertrophy: is it really?
por: Mikolich, J Ronald, et al.
Publicado: (2013)

Left ventricular hypertrophy and geometry in type 2 diabetes patients with chronic kidney disease. An echocardiographic study
por: Bayauli, MP, et al.
Publicado: (2012)

Left ventricular hypertrophy detection using electrocardiographic signal
por: Liu, Cheng-Wei, et al.
Publicado: (2023)

Association of Interarm Systolic Blood Pressure Difference with Atherosclerosis and Left Ventricular Hypertrophy
por: Su, Ho-Ming, et al.
Publicado: (2012)

Independent Determinants of Appetite Impairment among Patients with Stage 3 or Higher Chronic Kidney Disease: A Prospective Study
por: Sung, Chih-Chien, et al.
Publicado: (2021)

Myocardial Energetics in Left Ventricular Hypertrophy
por: Jameel, Mohammad N, et al.
Publicado: (2009)

Adherence to the Mediterranean Diet Is Associated with a More Favorable Left Ventricular Geometry in Patients with End-Stage Kidney Disease
por: Bacharaki, Dimitra, et al.
Publicado: (2022)

Modified technique for left ventricular assist device insertion in the setting of apical calcification
por: Mangukia, Chirantan, et al.
Publicado: (2021)

High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep Learning
por: Duffy, Grant, et al.
Publicado: (2022)

Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease
por: Meuwese, Christiaan Lucas, et al.
Publicado: (2015)

Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers
por: Bacharova, Ljuba, et al.
Publicado: (2023)

Machine learning-based investigation of the relationship between immune status and left ventricular hypertrophy in patients with end-stage kidney disease
por: Yang, Min, et al.
Publicado: (2023)

Massive and rapid left ventricular calcification
por: Iwatani, Hirotsugu, et al.
Publicado: (2009)

Left ventricular geometry predicts ventricular tachyarrhythmia in patients with left ventricular systolic dysfunction: a comprehensive cardiovascular magnetic resonance study
por: Nakamori, Shiro, et al.
Publicado: (2017)

Improved scoring system for the electrocardiographic diagnosis of left ventricular hypertrophy
por: Braunstein, Eric D, et al.
Publicado: (2019)

Fetuin-A and vascular calcification in Indian end-stage renal disease population
por: Mann, A., et al.
Publicado: (2016)

Estimated Glomerular Filtration Rate and Systolic Time Intervals in Risk Stratification for Increased Left Ventricular Mass Index and Left Ventricular Hypertrophy
por: Lee, Wen-Hsien, et al.
Publicado: (2016)

Risk Factors Associated With Altered Circulating MicroRNA‐125b and Their Influences on Uremic Vascular Calcification Among Patients With End‐Stage Renal Disease
por: Chao, Chia‐Ter, et al.
Publicado: (2019)

Association of Left Ventricular Hypertrophy With a Faster Rate of Renal Function Decline in Elderly Patients With Non‐End‐Stage Renal Disease
por: Shi, Hong‐tao, et al.
Publicado: (2015)

Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening
por: Xanthakis, Vanessa, et al.
Publicado: (2013)

Electrocardiographic Criteria for Left Ventricular Hypertrophy in Children
por: Rijnbeek, Peter R., et al.
Publicado: (2008)

The Role of ECG in the Diagnosis of Left Ventricular Hypertrophy
por: Bacharova, Ljuba, et al.
Publicado: (2014)

Left ventricular hypertrophy, inflammation, and insulin resistance
por: Öncel, Can Ramazan
Publicado: (2016)

Crim1 suppresses left ventricular hypertrophy
por: Yang, Long, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8nnj3tj7vfjtur31i2f08f744r